An updated view of hemostasis: mechanisms of hemostatic dysfuntion associated with sepsis

被引:42
作者
Hopper, K
Bateman, S
机构
[1] Univ Calif Davis, Dept Surg & Radiol, Sch Vet Med, Davis, CA 95616 USA
[2] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA
关键词
anti-thrombin; disseminated intravascular coagulation; fibrinolysis; protein C; tissue factor; tissue factor pathway inhibitor;
D O I
10.1111/j.1476-4431.2005.00128.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective: To review the current understanding of mechanisms involved in normal hemostasis and to describe the changes associated with pro-inflammatory disease processes such as sepsis. Data sources: Original research articles and scientific reviews. Human data synthesis: Organ damage caused by sepsis is created in part by the interdependent relationship between hemostasis and inflammation. Markers of coagulation have been found to have prognostic value in human patients with sepsis and there are both experimental and clinical investigations of the therapeutic potential of modulating the hemostatic system in sepsis. Improvement of 28-day all-cause mortality in severe sepsis by treatment with recombinant human activated Protein C strongly supports the interdependence of hemostasis and inflammation in the pathophysiology of sepsis. Veterinary data synthesis: Publications reporting clinical evaluation of the hemostatic changes occurring in septic dogs or cats are minimal. Experimental animal models of sepsis reveal significant similarity between human and animal sepsis and may provide relevance to clinical veterinary medicine until prospective clinical evaluations are published. Conclusions: It is now apparent that inflammation and the coagulation system are intimately connected. Understanding this relationship provides some insight into the pathogenesis of the hemostatic changes associated with sepsis. This new updated view of hemostasis may lead to the development of novel therapeutic approaches to sepsis and disseminated intravascular coagulation in veterinary medicine.
引用
收藏
页码:83 / 91
页数:9
相关论文
共 101 条
[1]   Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].
Abraham, E ;
Reinhart, K ;
Opal, S ;
Demeyer, I ;
Doig, C ;
Rodriguez, AL ;
Beale, R ;
Svoboda, P ;
Laterre, PF ;
Simon, S ;
Light, B ;
Spapen, H ;
Stone, J ;
Seibert, A ;
Peckelsen, C ;
De Deyne, C ;
Postier, R ;
Pettilä, V ;
Sprung, CL ;
Artigas, A ;
Percell, SR ;
Shu, V ;
Zwingelstein, C ;
Tobias, J ;
Poole, L ;
Stolzenbach, JC ;
Creasey, AA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247
[2]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[3]   Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms [J].
Ariëns, RAS ;
Lai, TS ;
Weisel, JW ;
Greenberg, CS ;
Grant, PJ .
BLOOD, 2002, 100 (03) :743-754
[4]   Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases [J].
Asakura, H ;
Ontachi, Y ;
Mizutani, T ;
Kato, M ;
Saito, M ;
Morishita, E ;
Yamazaki, M ;
Suga, Y ;
Takami, A ;
Miyamoto, K ;
Nakao, S .
BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (01) :1-8
[5]   TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex [J].
Bajzar, L ;
Morser, J ;
Nesheim, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16603-16608
[6]   Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia [J].
Barton, MH ;
Morris, DD ;
Norton, N ;
Prasse, KW .
JOURNAL OF VETERINARY INTERNAL MEDICINE, 1998, 12 (01) :26-35
[7]   Regulation of angiogenesis by tissue factor cytoplasmic domain signaling [J].
Belting, M ;
Dorrell, MI ;
Sandgren, S ;
Aguilar, E ;
Ahamed, J ;
Dorfleutner, A ;
Carmeliet, P ;
Mueller, BM ;
Friedlander, M ;
Ruf, W .
NATURE MEDICINE, 2004, 10 (05) :502-509
[8]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[9]  
Blanchette V S, 1991, Baillieres Clin Haematol, V4, P291, DOI 10.1016/S0950-3536(05)80162-3
[10]   Severe sepsis in cats: 29 cases (1986-1998) [J].
Brady, CA ;
Otto, CM ;
Van Winkle, TJ ;
King, LG .
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2000, 217 (04) :531-535